Safety and Pharmacokinetics (PK) of Escalating Doses of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Locally Advanced or Metastatic Tumors
-
Cancer -
Solid Tumors -
Advanced Solid Tumors -
Metastatic Solid Tumors
For the latest version of this information please go to www.forpatients.roche.com